Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$107.32 - $113.5 $1.34 Million - $1.42 Million
-12,517 Reduced 54.3%
10,535 $1.15 Million
Q4 2022

Feb 15, 2023

SELL
$62.39 - $113.8 $5.62 Million - $10.2 Million
-90,039 Reduced 79.62%
23,052 $2.62 Million
Q3 2022

Oct 27, 2022

SELL
$58.92 - $84.67 $1.93 Million - $2.77 Million
-32,677 Reduced 22.42%
113,091 $7 Million
Q2 2022

Aug 01, 2022

BUY
$79.4 - $116.36 $149,669 - $219,338
1,885 Added 1.31%
145,768 $11.6 Million
Q1 2022

Apr 26, 2022

BUY
$86.42 - $109.81 $1.19 Million - $1.51 Million
13,778 Added 10.59%
143,883 $15.1 Million
Q4 2021

Feb 15, 2022

SELL
$98.56 - $119.91 $103,290 - $125,665
-1,048 Reduced 0.8%
130,105 $14 Million
Q3 2021

Nov 16, 2021

SELL
$91.91 - $110.37 $391,628 - $470,286
-4,261 Reduced 3.15%
131,153 $14.4 Million
Q2 2021

Jul 19, 2021

BUY
$86.24 - $95.92 $575,393 - $639,978
6,672 Added 5.18%
135,414 $12.7 Million
Q1 2021

May 03, 2021

SELL
$71.83 - $95.48 $295,652 - $392,995
-4,116 Reduced 3.1%
128,742 $11.9 Million
Q4 2020

Feb 09, 2021

SELL
$67.0 - $84.39 $439,118 - $553,092
-6,554 Reduced 4.7%
132,858 $9.72 Million
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $2.36 Million - $3.42 Million
-42,808 Reduced 23.49%
139,412 $10.8 Million
Q2 2020

Jul 29, 2020

SELL
$30.2 - $56.98 $837,415 - $1.58 Million
-27,729 Reduced 13.21%
182,220 $10.1 Million
Q1 2020

Apr 30, 2020

BUY
$24.87 - $38.56 $1.58 Million - $2.46 Million
63,721 Added 43.58%
209,949 $6.22 Million
Q4 2019

Jan 29, 2020

SELL
$25.43 - $36.67 $2.23 Million - $3.22 Million
-87,692 Reduced 37.49%
146,228 $5.29 Million
Q3 2019

Oct 29, 2019

BUY
$23.0 - $27.97 $1.54 Million - $1.87 Million
66,878 Added 40.04%
233,920 $6.37 Million
Q2 2019

Aug 19, 2019

BUY
$22.81 - $28.48 $3.81 Million - $4.76 Million
167,042 New
167,042 $4.02 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.